The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 956
ISSUE 956
September 1, 1995
Issue 956
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Moexipril: Another ACE Inhibitor For Hypertension
September 1, 1995 (Issue: 956)
Moexipril hydrochloride (Univasc - Schwarz Pharma), an angiotensin-converting enzyme (ACE) inhibitor, was recently approved by the US Food and Drug Administration (FDA) for treatment of. It is the eighth ACE inhibitor to be marketed in the...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.